Literature DB >> 21210235

Persistent roles of signal transduction of platelet-derived growth factor B in genesis, growth, and anaplastic transformation of gliomas in an in-vivo serial transplantation model.

Rina Torisu1, Satoshi O Suzuki, Kenta Masui, Koji Yoshimoto, Masahiro Mizoguchi, Makoto Hashizume, Peter Canoll, James E Goldman, Tomio Sasaki, Toru Iwaki.   

Abstract

We previously reported that retrovirally transduced platelet-derived growth factor-B (PDGFB) in glial progenitors of the rat cerebral white matter, subventricular zone, or brain stem induced malignant brain tumors closely resembling human glioblastoma (GBM). While human GBMs may progress over the period of several months to a few years, prospective, long-term in-vivo observation of histological changes of the tumor tissues is not feasible in these models, because the animals undergo rapid tumor progression and mortality within approximately 1 month. We thus performed successive, long-term in-vivo transplantation of the PDGFB-induced tumor cells into the rat cerebrum. Primary retroviral transduction of PDGFB in the glial progenitors of the rat basal ganglia induced malignant glioma resembling human GBM or anaplastic oligodendroglioma (AOL) consisting of relatively monomorphous tumor cells expressing markers for the oligodendrocyte lineage. In the course of long-term successive transplantation, tumor cells presented pleomorphism as well as focal GFAP expression. This suggests that secondary chromosomal aberration and dysregulation of gene expression following accelerated cell cycle by PDGFB stimulation would induce morphological and immunophenotypic changes in tumor cells. Furthermore, while the primary tumors contained only a minor fraction of proviral GFP-expressing or hemagglutinin-expressing cells, most tumor cells came to express these proviral genes in the course of serial transplantation suggesting a persistent role of PDGFB-expressing cells in maintenance and growth of the tumors. This model would be useful for investigation of the long-term effects of PDGFB stimulation in glioma tissues on anaplastic evolution.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21210235      PMCID: PMC3862171          DOI: 10.1007/s10014-010-0006-0

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  27 in total

1.  Heterogeneity of cycling glial progenitors in the adult mammalian cortex and white matter.

Authors:  J M Gensert; J E Goldman
Journal:  J Neurobiol       Date:  2001-08

Review 2.  Glioma classification: a molecular reappraisal.

Authors:  D N Louis; E C Holland; J G Cairncross
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

3.  A2B5+ and O4+ Cycling progenitors in the adult forebrain white matter respond differentially to PDGF-AA, FGF-2, and IGF-1.

Authors:  J L Mason; J E Goldman
Journal:  Mol Cell Neurosci       Date:  2002-05       Impact factor: 4.314

4.  FGF modulates the PDGF-driven pathway of oligodendrocyte development.

Authors:  R D McKinnon; T Matsui; M Dubois-Dalcq; S A Aaronson
Journal:  Neuron       Date:  1990-11       Impact factor: 17.173

5.  Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell.

Authors:  M Noble; K Murray; P Stroobant; M D Waterfield; P Riddle
Journal:  Nature       Date:  1988-06-09       Impact factor: 49.962

6.  Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells.

Authors:  O Bögler; D Wren; S C Barnett; H Land; M Noble
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

7.  Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis.

Authors:  Alan H Shih; Chengkai Dai; Xiaoyi Hu; Marc K Rosenblum; Jason A Koutcher; Eric C Holland
Journal:  Cancer Res       Date:  2004-07-15       Impact factor: 12.701

8.  Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors.

Authors:  T P Fleming; A Saxena; W C Clark; J T Robertson; E H Oldfield; S A Aaronson; I U Ali
Journal:  Cancer Res       Date:  1992-08-15       Impact factor: 12.701

9.  Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines.

Authors:  M Nistér; T A Libermann; C Betsholtz; M Pettersson; L Claesson-Welsh; C H Heldin; J Schlessinger; B Westermark
Journal:  Cancer Res       Date:  1988-07-15       Impact factor: 12.701

10.  Complementary effects of platelet-derived growth factor autocrine stimulation and p53 or Ink4a-Arf deletion in a mouse glioma model.

Authors:  Göran Hesselager; Lene Uhrbom; Bengt Westermark; Monica Nistér
Journal:  Cancer Res       Date:  2003-08-01       Impact factor: 12.701

View more
  3 in total

Review 1.  Review: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies.

Authors:  K Masui; T F Cloughesy; P S Mischel
Journal:  Neuropathol Appl Neurobiol       Date:  2012-06       Impact factor: 8.090

2.  PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma.

Authors:  Pedro M Costa; Ana L Cardoso; Luis F Pereira de Almeida; Jeffrey N Bruce; Peter Canoll; Maria C Pedroso de Lima
Journal:  Hum Mol Genet       Date:  2012-08-24       Impact factor: 6.150

3.  Identification of VHY/Dusp15 as a regulator of oligodendrocyte differentiation through a systematic genomics approach.

Authors:  Fanny Schmidt; Monique van den Eijnden; Rosanna Pescini Gobert; Gabriela P Saborio; Susanna Carboni; Chantal Alliod; Sandrine Pouly; Susan M Staugaitis; Ranjan Dutta; Bruce Trapp; Rob Hooft van Huijsduijnen
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.